Volume 4, Issue 2 (12-2022)                   pbp 2022, 4(2): 89-102 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akhzari M, Shabani-Borujeni M, Tavakoli R, Siahkohi H, Mottaghiyan Z, Fathi J, et al . Zingiber officinale (Ginger) Properties in Clinical Trials; A Brief Review. pbp 2022; 4 (2) :89-102
URL: http://pbp.medilam.ac.ir/article-1-165-en.html
1- Larestan University of Medical Sciences, Shiraz, Iran
2- Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
3- Student Research Committee, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
4- Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran
5- Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran
6- Department of Medical Bacteriology and Virology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
7- Department of Microbiology, Ardabil Branch, Islamic Azad University, Ardabil, Iran
8- Department of Clinical Biochemistry, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran , shafieem@sums.ac.ir
Abstract:   (1091 Views)
Objective: Zingiber officinale (Ginger) is a flowering plant that was once utilized in Chinese medicine, Indian medicine, and Greek herbal therapy to treat many illnesses.
Results: Different parts of this plant, for example, roots and rhizomes, and its extract are widely used as a spice and traditional medicine. It has been shown that ginger has several therapeutic properties, including reducing inflammation, preventing cancer, lowering blood sugar and lipids, regulating the immune system, anti-apoptotic and anti-nausea, and anti-vomiting effects. In addition, nervous diseases, colds, rheumatism, gingivitis, toothaches, asthma, stroke, constipation, and diabetes have been treated with ginger. Ginger is also a powerful antioxidant and can prevent the production and activity of free radicals. Moreover, ginger extract has been utilized as a diaphoretic and anti-flatulent medication for gastrointestinal spasms. It's also used to treat indigestion and colic pain in the intestines.
Conclusion: In this contribution, we provide an overview of various reports of ginger properties in clinical studies and its effects on the treatment of diseases. In addition to summarizing the present literature. This study highlights the potential of this field to open up new avenues for researchers.
 
Full-Text [PDF 5350 kb]   (230 Downloads)    
Type of Study: Research | Subject: Herbal Drugs
Received: 2022/11/22 | Accepted: 2022/11/23 | Published: 2022/11/23

References
1. Ali, B.H., et al., Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and chemical Toxicology, 2008. 46(2): p. 409-420.
2. Singletary, K., Ginger: an overview of health benefits. Nutrition Today, 2010. 45(4): p. 171-183.
3. Shirdel, Z., R. Mirbadalzadeh, and H. Madani, Antidiabetic and antilipidemic effect of ginger in alloxan monohydrate diabetic rats in comparison with glibenclamide. Iran J Diabetes Lipid Disord, 2009. 9(1): p. 7-15.
4. O'Hara, M., et al., A review of 12 commonly used medicinal herbs. Archives of family medicine, 1998. 7(6): p. 523.
5. Kumar, S., et al., Anti-inflammatory action of ginger: A critical review in anemia of inflammation and its future aspects. Int J Herb Med, 2013. 1: p. 16-20.
6. Wang, W. and Z. Wang, Studies of commonly used traditional medicine-ginger. Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China journal of Chinese materia medica, 2005. 30(20): p. 1569-1573.
7. Jolad, S.D., et al., Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production. Phytochemistry, 2004. 65(13): p. 1937-1954.
8. Tjendraputra, E., et al., Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorganic chemistry, 2001. 29(3): p. 156-163.
9. van Breemen, R.B., Y. Tao, and W. Li, Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale). Fitoterapia, 2011. 82(1): p. 38-43.
10. Grzanna, R., L. Lindmark, and C.G. Frondoza, Ginger—an herbal medicinal product with broad anti-inflammatory actions. Journal of medicinal food, 2005. 8(2): p. 125-132.
11. Shen, C.-L., K.-J. Hong, and S.W. Kim, Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes. Journal of medicinal food, 2005. 8(2): p. 149-153.
12. Ahui, M.L.B., et al., Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation. International immunopharmacology, 2008. 8(12): p. 1626-1632.
13. Jelled, A., et al., Chemical and antioxidant parameters of dried forms of ginger rhizomes. Industrial Crops and Products, 2015. 77: p. 30-35.
14. Khalili, M., et al., Effects of alcoholic extract of Zingiber officinalis rhizome on acute and chronic inflammation and pain in rats. Koomesh, 2010. 12(2).
15. Kim, M.K., et al., Modulation of age-related NF-κB activation by dietary zingerone via MAPK pathway. Experimental gerontology, 2010. 45(6): p. 419-426.
16. Shimoda, H., et al., Anti-inflammatory properties of red ginger (Zingiber officinale var. Rubra) extract and suppression of nitric oxide production by its constituents. Journal of medicinal food, 2010. 13(1): p. 156-162.
17. Levy, A. and O. Simon, Six-shogaol inhibits production of tumour necrosis factor alpha, interleukin-1 beta and nitric oxide from lipopolysaccharide-stimulated RAW 264.7 macrophages. West Indian med. j, 2009: p. 295-300.
18. Sabina, E.P., et al., 6-Shogaol inhibits monosodium urate crystal-induced inflammation–An in vivo and in vitro study. Food and Chemical Toxicology, 2010. 48(1): p. 229-235.
19. Chung, S.W., et al., Peroxisome proliferator-activated receptor activation by a short-term feeding of zingerone in aged rats. Journal of medicinal food, 2009. 12(2): p. 345-350.
20. Lee, H.Y., et al., 1‐Dehydro‐[10]‐gingerdione from ginger inhibits IKKβ activity for NF‐κB activation and suppresses NF‐κB‐regulated expression of inflammatory genes. British journal of pharmacology, 2012. 167(1): p. 128-140.
21. Hegazy, H.G., Ameliorative effects of ginger and-Lipoic acid on oxidative stress and inflammation in senile female rats. African Journal of Pharmacy and Pharmacology, 2011. 5(8): p. 1096-1105.
22. Lantz, R., et al., The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine, 2007. 14(2-3): p. 123-128.
23. گمار, میرازی, and گمار, بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار. مجله علمی دانشگاه علوم پزشکی ایلام, 2014. 22(4): p. 74-82.
24. Ghasemzadeh, A., H.Z. Jaafar, and A. Rahmat, Antioxidant activities, total phenolics and flavonoids content in two varieties of Malaysia young ginger (Zingiber officinale Roscoe). Molecules, 2010. 15(6): p. 4324-4333.
25. Dickenson, A.H., Neurophysiology of opioid poorly responsive pain. Cancer surveys, 1994. 21: p. 5-16.
26. Toker, G., et al., Flavonoids with antinociceptive and anti-inflammatory activities from the leaves of Tilia argentea (silver linden). Journal of Ethnopharmacology, 2004. 95(2-3): p. 393-397.
27. Ghayur, M.N., et al., Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascular pharmacology, 2005. 43(4): p. 234-241.
28. Aimbire, F., et al., Effect of hydroalcoholic extract of Zingiber officinalis rhizomes on LPS-induced rat airway hyperreactivity and lung inflammation. Prostaglandins, leukotrienes and essential fatty acids, 2007. 77(3-4): p. 129-138.
29. Raji, Y., et al., Anti-flammatory and analgesic properties of the rhizome extract of Zingiber officinale. African Journal of Biomedical Research, 2002. 5(3).
30. Li, X.H., et al., Attenuation of liver pro‐inflammatory responses by Zingiber officinale via inhibition of NF‐kappa B activation in high‐fat diet‐fed rats. Basic & clinical pharmacology & toxicology, 2012. 110(3): p. 238-244.
31. Rodrigues, F.A., et al., Gingerol fraction from Zingiber officinale protects against gentamicin-induced nephrotoxicity. Antimicrobial agents and chemotherapy, 2014. 58(4): p. 1872-1878.
32. Guahk, G.-H., et al., Zingiber officinale protects HaCaT cells and C57BL/6 mice from ultraviolet B-induced inflammation. Journal of medicinal food, 2010. 13(3): p. 673-680.
33. HUANG, Q., et al., Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger. Chemical and pharmaceutical bulletin, 1991. 39(2): p. 397-399.
34. 34. Muller, W., B.L. Fiebich, and T. Stratz, New treatment options using 5-HT3 receptor antagonists in rheumatic diseases. Current topics in medicinal chemistry, 2006. 6(18): p. 2035-2042.
35. Mu, J., et al., Interspecies communication between plant and mouse gut host cells through edible plant derived exosome‐like nanoparticles. Molecular nutrition & food research, 2014. 58(7): p. 1561-1573.
36. Habib, S.H.M., et al., Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics, 2008. 63: p. 807-813.
37. de Lima, R.M.T., et al., Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]‐gingerol in cancer: A comprehensive review. Phytotherapy research, 2018. 32(10): p. 1885-1907.
38. Aeschbach, R., et al., Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food and Chemical Toxicology, 1994. 32(1): p. 31-36.
39. Fischer, S. and M. Glei, Herbs and Spices Overview on the possible health-promoting Effects. Ernahrungs Umschau, 2016. 63(11): p. 222-227.
40. MA, A., Effects of combination of long-term ginger consumption and resistance training on lipid peroxidation and insulin resistance in obese men. 2012.
41. Afshari, A.T., et al., The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats. Food chemistry, 2007. 101(1): p. 148-153.
42. Shukla, Y. and M. Singh, Cancer preventive properties of ginger: a brief review. Food and chemical toxicology, 2007. 45(5): p. 683-690.
43. Flynn, D.L., M.F. Rafferty, and A.M. Boctor, Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins, Leukotrienes and Medicine, 1986. 24(2-3): p. 195-198.
44. Surh, Y.-J., Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 1999. 428(1-2): p. 305-327.
45. Yoshimi, N., et al., Modifying effects of fungal and herb metabolites on azoxymethane‐induced intestinal carcinogenesis in rats. Japanese Journal of Cancer Research, 1992. 83(12): p. 1273-1278.
46. Park, K.-K., et al., Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer letters, 1998. 129(2): p. 139-144.
47. Bode, A. Ginger is an effective inhibitor of HCT116 human colorectal carcinoma in vivo. 2003. Frontiers in Cancer Prevention Research Conference.
48. Manju, V. and N. Nalini, Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1, 2 dimethylhydrazine-induced colon cancer. Clinica Chimica Acta, 2005. 358(1-2): p. 60-67.
49. Nagasawa, H., K. Watanabe, and H. Inatomi, Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice. The American journal of Chinese medicine, 2002. 30(02n03): p. 195-205.
50. Kim, E.-C., et al., [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochemical and biophysical research communications, 2005. 335(2): p. 300-308.
51. Suzuki, F., et al., Keishi-ka-kei-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma. Anticancer research, 1997. 17(2A): p. 873-878.
52. TAVAKOL, A.J., N. Moheghi, and A. Brouk, Ethanolic extract cytotoxic effect of zingiber officinale in hepatocellular carcinoma (hepg2) cell line. 2010.
53. Liu, Y., et al., Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53. PloS one, 2012. 7(12): p. e53178.
54. Vijaya Padma, V., S. Arul Diana Christie, and K.M. Ramkuma, Induction of apoptosis by Ginger in HEp‐2 cell line is mediated by reactive oxygen species. Basic & clinical pharmacology & toxicology, 2007. 100(5): p. 302-307.
55. Ramakrishnan, R., Anticancer properties of Zingiber officinale–Ginger: A review. Int. J. Med. Pharm. Sci, 2013. 3: p. 11-20.
56. Karaboz, I., Antimicrobial and cytotoxic activities of Zingiber officinalis extracts. FABAD J. Pharm. Sci, 2010. 33: p. 76-85.
57. Bernard, M.M., J.R. McConnery, and D.W. Hoskin, [10]-Gingerol, a major phenolic constituent of ginger root, induces cell cycle arrest and apoptosis in triple-negative breast cancer cells. Experimental and molecular pathology, 2017. 102(2): p. 370-376.
58. Wei, Q.-Y., et al., Cytotoxic and apoptotic activities of diarylheptanoids and gingerol-related compounds from the rhizome of Chinese ginger. Journal of ethnopharmacology, 2005. 102(2): p. 177-184.
59. Lee, S.H., M. Cekanova, and S.J. Baek, Multiple mechanisms are involved in 6‐gingerol‐induced cell growth arrest and apoptosis in human colorectal cancer cells. Molecular Carcinogenesis: Published in cooperation with the University of Texas MD Anderson Cancer Center, 2008. 47(3): p. 197-208.
60. Elkady, A.I., et al., Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale. Journal of Biomedicine and Biotechnology, 2012. 2012.
61. Talaei, B., et al., The effect of ginger on blood glucose, lipid and lipoproteins in patients with type 2 diabetes: a double-blind randomized clinical controlled trial. SSU_Journals, 2012. 20(3): p. 383-95.
62. Shidfar, F., et al., The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. Journal of Complementary and Integrative Medicine, 2015. 12(2): p. 165-170.
63. Mahluji, S., et al., Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. International journal of food sciences and nutrition, 2013. 64(6): p. 682-686.
64. Jafarnejad, S., et al., Effect of ginger (Zingiber officinale) on blood glucose and lipid concentrations in diabetic and hyperlipidemic subjects: a meta-analysis of randomized controlled trials. Journal of functional foods, 2017. 29: p. 127-134.
65. Arablou, T., et al., The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. International journal of food sciences and nutrition, 2014. 65(4): p. 515-520.
66. Verma, S., et al., Protective effect of ginger, Zingiber officinale Rosc on experimental atherosclerosis in rabbits. 2004.
67. Bhandari, U. and K. Pillai, Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. Journal of ethnopharmacology, 2005. 97(2): p. 227-230.
68. بیشک, خ., et al., مروری بر کاربردهای درمانی زنجبیل از دیدگاه علم نوین و طب سنتی اسلامی. مجله طب سنتی اسلام و ایران, 2018. 9(3): p. 239-250.
69. Zhang, X. and B. Tan, Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats. Singapore medical journal, 2000. 41(1): p. 9-13.
70. Henriksen, E.J., Exercise training and the antioxidant α-lipoic acid in the treatment of insulin resistance and type 2 diabetes. Free Radical Biology and Medicine, 2006. 40(1): p. 3-12.
71. Kazeem, M.I., et al., Antiglycation and hypolipidemic effects of polyphenols from Zingiber officinale Roscoe (Zingiberaceae) in streptozotocin-induced diabetic rats. Tropical journal of pharmaceutical research, 2015. 14(1): p. 55-61.
72. Shanmugam, K.R., et al., Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food and chemical toxicology, 2011. 49(4): p. 893-897.
73. Nammi, S., S. Sreemantula, and B.D. Roufogalis, Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high‐fat diet‐fed rats. Basic & clinical pharmacology & toxicology, 2009. 104(5): p. 366-373.
74. Goyal, R.K. and S.V. Kadnur, Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia, 2006. 77(3): p. 160-163.
75. Li, Y., et al., Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evidence-Based Complementary and Alternative Medicine, 2012. 2012.
76. Isa, Y., et al., 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications, 2008. 373(3): p. 429-434.
77. Atashak, S., M. Peeri, and A. Jafari, Effects of 10 week resistance training and ginger consumption on C-reactive protein and some cardiovascular risk factors in obese men. Physiology and Pharmacology, 2010. 14(3): p. 318-328.
78. Alizadeh-Navaei, R., et al., Investigation of the effect of ginger on the lipid levels. Saudi Med J, 2008. 29(9): p. 1280-4.
79. Amir Sasan, R., S.S. Vahid, and P. Karimi, Effect of simulated intermittent altitude on the metabolic and hematologic parameters in streptozotocin induced diabetic rats. Journal of Ardabil University of Medical Sciences, 2016. 16(1): p. 53-64.
80. Navael Reza, A., et al., Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. 2008.
81. Elshater, A.-E.A., M. Salman, and M. Moussa, Effect of ginger extract consumption on levels of blood glucose, lipid profile and kidney functions in alloxan induced-diabetic rats. Egyptian Academic Journal of Biological Sciences. A, Entomology, 2009. 2(1): p. 153-162.
82. Al-Amin, Z.M., et al., Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. British journal of nutrition, 2006. 96(4): p. 660-666.
83. Akhani, S.P., S.L. Vishwakarma, and R.K. Goyal, Anti‐diabetic activity of Zingiber officinale in streptozotocin‐induced type I diabetic rats. Journal of pharmacy and Pharmacology, 2004. 56(1): p. 101-105.
84. Kim, Y., D.M. Kim, and J.Y. Kim, Ginger Extract Suppresses Inflammatory Response and Maintains Barrier Function in Human Colonic Epithelial Caco‐2 Cells Exposed to Inflammatory Mediators. Journal of food science, 2017. 82(5): p. 1264-1270.
85. Aktan, F., et al., Gingerol metabolite and a synthetic analogue Capsarol™ inhibit macrophage NF-κB-mediated iNOS gene expression and enzyme activity. Planta medica, 2006. 72(08): p. 727-734.
86. Farzin, D., et al., Efficacy of ginger in patients uncontrolled on standard moderate asthma treatment. Journal of Mazandaran University of Medical Sciences, 2012. 21(1): p. 137-140.
87. Roohi Broujeni, H., F. Ganji, and P. Roohi Broujeni, The effect of combination of Zingeber and Althea officinalis extracts in acute bronchitis-induced cough. journal of shahrekord university of medical sciences, 2009. 10(4).
88. Williams, A.S., et al., Interferon‐γ protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 2007. 56(7): p. 2244-2254.
89. Keum, Y.-S., et al., Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer letters, 2000. 150(1): p. 41-48.
90. Basirat, Z., et al., The effect of ginger biscuit on nausea and vomiting in early pregnancy. Acta Medica Iranica, 2009: p. 51-56.
91. Oboh, G., A.J. Akinyemi, and A.O. Ademiluyi, Antioxidant and inhibitory effect of red ginger (Zingiber officinale var. Rubra) and white ginger (Zingiber officinale Roscoe) on Fe2+ induced lipid peroxidation in rat brain in vitro. Experimental and toxicologic pathology, 2012. 64(1-2): p. 31-36.
92. Brown, A.C., et al., Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 2009. 23(5): p. 640-645.
93. Samuels, N., Herbal remedies and anticoagulant therapy. Thrombosis and haemostasis, 2005. 93(01): p. 03-07.
94. Terry, R., et al., The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain medicine, 2011. 12(12): p. 1808-1818.
95. Gahlinger, P.M., Motion sickness: How to help your patients avoid travel travail. Postgraduate medicine, 1999. 106(4): p. 177-184.
96. Lien, H.-C., et al., Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2003. 284(3): p. G481-G489.
97. Haniadka, R., et al., A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe). Food & function, 2013. 4(6): p. 845-855.
98. Blunt, J.W., et al., Marine natural products. Natural Product Reports, 2016. 33(3): p. 382-431.
99. Smith, C., et al., A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstetrics & Gynecology, 2004. 103(4): p. 639-645.
100. Sripramote, M. and N. Lekhyananda, A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy. Journal of the Medical Association of Thailand= Chotmaihet Thangphaet, 2003. 86(9): p. 846-853.
101. Hematzadeh, S., et al., The comparison of ginger and metoclopramid in treatment of pregnant women’s nausea and vomiting. 2007.
102. Ozgoli, G., et al., Ginger for nausea and vomiting in pregnancy. 2004.
103. Ozgoli, G., M. Goli, and F. Moattar, Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. The journal of alternative and complementary medicine, 2009. 15(2): p. 129-132.
104. Chittumma, P., K. Kaewkiattikun, and B. Wiriyasiriwach, Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial. Journal-medical association of thailand, 2007. 90(1): p. 15.
105. Chaiyakunapruk, N., et al., The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. American journal of obstetrics and gynecology, 2006. 194(1): p. 95-99.
106. Sontakke, S., V. Thawani, and M. Naik, Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: a randomized, cross-over, double blind study. Indian journal of pharmacology, 2003. 35(1): p. 32-36.
107. Pillai, A.K., et al., Anti‐emetic effect of ginger powder versus placebo as an add‐on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatric blood & cancer, 2011. 56(2): p. 234-238.
108. Vishwakarma, S., et al., Anxiolytic and antiemetic activity of Zingiber officinale. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 2002. 16(7): p. 621-626.
109. Pongrojpaw, D., C. Somprasit, and A. Chanthasenanont, A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy. Journal-Medical Association of Thailand, 2007. 90(9): p. 1703.
110. Apariman, S., S. Ratchanon, and B. Wiriyasirivej, Effectiveness of ginger for prevention of nausea and vomiting after gynecological laparoscopy. Journal-Medical Association of Thailand, 2006. 89(12): p. 2003.
111. Nicoll, R. and M.Y. Henein, Ginger (Zingiber officinale Roscoe): a hot remedy for cardiovascular disease? International journal of cardiology, 2009. 131(3): p. 408-409.
112. Rho, Y.H., et al., Drugs used in the treatment of rheumatoid arthritis: relationship between current use and cardiovascular risk factors. Archives of drug information, 2009. 2(2): p. 34-40.
113. Koo, K.L., et al., Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation. Thrombosis research, 2001. 103(5): p. 387-397.
114. Chaudhary, S., P.K. Godatwar, and R. Sharma, In vitro thrombolytic activity of Dhamasa (Fagonia arabica Linn.), Kushta (Saussurea lappa Decne.), and Guduchi (Tinospora cordifolia Thunb.). Ayu, 2015. 36(4): p. 421.
115. Young, H.-Y., et al., Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers. The American journal of Chinese medicine, 2006. 34(04): p. 545-551.
116. Gencer, B., et al., Use and role of monoclonal antibodies and other biologics in preventive cardiology. Swiss medical weekly, 2015. 145: p. w14179.
117. Ozgoli, G., M. Goli, and M. Simbar, Effects of ginger capsules on pregnancy, nausea, and vomiting. The Journal of Alternative and Complementary Medicine, 2009. 15(3): p. 243-246.
118. Black, C.D. and P.J. O’Connor, Acute effects of dietary ginger on quadriceps muscle pain during moderate-intensity cycling exercise. International journal of sport nutrition and exercise metabolism, 2008. 18(6): p. 653-664.
119. Wachtel-Galor, S., et al., Ganoderma lucidum (Lingzhi or Reishi), in Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. 2011, CRC Press/Taylor & Francis.
120. Weiss, R. and V. Fintelmann, Herbal Medicine 2nd edn revised and expanded. 2000, Germany: Georg Thieme Verlag.
121. Jeena, K., et al., Antimutagenic potential and modulation of carcinogen‐metabolizing enzymes by ginger essential oil. Phytotherapy Research, 2014. 28(6): p. 849-855.
122. Weidner, M.S. and K. Sigwart, Investigation of the teratogenic potential of a Zingiber officinale extract in the rat. Reproductive Toxicology, 2000. 15(1): p. 75-80.
123. Khare, C.P., Indian herbal remedies: rational Western therapy, ayurvedic, and other traditional usage, Botany. 2004: Springer science & business media.
124. Sepahvand, R., et al., Ginger (Zingiber officinale Roscoe) elicits antinociceptive properties and potentiates morphine-induced analgesia in the rat radiant heat tail-flick test. Journal of medicinal food, 2010. 13(6): p. 1397-1401.
125. Torkzadeh-Mahani, S., S. Nasri, and S. Esmaeili-Mahani, Ginger (zingiber officinale roscoe) prevents morphine-induced addictive behaviors in conditioned place preference test in rats. Addiction & health, 2014. 6(1-2): p. 65.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.